Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00621933 · ClinicalTrials.gov registry record
Surveillance of Ocular Surface Flora (SURFACE)
A clinical trial, sponsored by Allergan.
- Completed
- Registry status
- 399
- Enrollment target
NCT00621933: Completed study, sponsored by Allergan.
NCT00621933 is a clinical trial that has completed, run by Allergan. The registered enrollment target is 399 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00621933 has completed, sponsored by Allergan.
- COMPLETED
- Registry status
- 399 participants
- Enrollment target
Study Summary
Topical fluoroquinolones (FQs) have achieved widespread use in ophthalmology for both the treatment and prophylaxis of ocular infections. The present study is set to determine the bacteria present on the ocular surface in patients at the time of cataract surgery and to assess the rate of resistance of ocular isolates to commonly used topical antibiotics.
Primary Outcome
Percentage of staphylococcus epidermidis species susceptible and resistant to oxacillin on the eyelid. The minimum inhibitory concentrations (MIC) of each species were determined and compared to oxacillin MIC breakpoints. MIC is the lowest concentration of an antimicrobial that inhibits the visible growth of a microorganism after incubation. For Staphylococcus epidermidis, the oxacillin MIC breakpoints were \<= 0.25 ug/ml (susceptible) and \>= 0.50 ug/ml (resistant).
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 399 participants |
| Start Date | 2007-12 |
| Est. Completion | 2008-11 |
What the finished NCT00621933 record still lists
NCT00621933 is an observational study that tracks outcomes without assigning an intervention. The registered 399 participants enrollment target is mid-sized for trials with a published cap.
The record links to 0 conditions, and to 0 interventions.
NCT00621933 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00621933 about?
NCT00621933 is a clinical study titled "Surveillance of Ocular Surface Flora (SURFACE)". Topical fluoroquinolones (FQs) have achieved widespread use in ophthalmology for both the treatment and prophylaxis of ocular infections. The present study is set to determine the bacteria present on the ocular surface in patients at the time of cataract surgery and to assess the rate of resistance ...
What is the current status of trial NCT00621933?
This trial is currently completed. The enrollment target is 399 participants. The study started on 2007-12. Estimated completion is 2008-11.
Who is sponsoring clinical trial NCT00621933?
This trial is sponsored by Allergan, which has 314 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03165734 · 399 participants · Phase 3
A Phase 3 Study of Pacritinib in Patients With Primary Myelofibrosis, Post Polycythemia Vera Myelofibrosis, or Post-Essential Thrombocythemia Myelofibrosis
- NCT05022862 · 399 participants · NA
Economic Incentives and vDOT for Latent Tuberculosis Infection
- NCT01665326 · 400 participants
Determination of CRIM Status and Longitudinal Follow-up of Individuals With Pompe Disease
- NCT02108054 · 400 participants · NA
Behavioral and Functional Task Development, Implementation, and Testing
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia